Log In
BCIQ
Print this Print this
 

Esmocard, esmolol HCl (Esmocard LYO)

  Manage Alerts
Collapse Summary General Information
Company AOP Orphan Pharmaceuticals AG
DescriptionCardioselective adrenergic receptor beta 1 (ADRB1) antagonist
Molecular Target Adrenergic receptor beta 1 (ADRB1)
Mechanism of ActionAdrenergic receptor beta 1 (ADRB1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationTachycardia
Indication DetailsPrevent tachycardia; Treat tachyarrhythmia, or atrial fibrillation and atrial flutter
Regulatory Designation
PartnerCardiome Pharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/12/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today